ZA200608305B - Pharmaceutical composition comprising a salt of mirtazapine - Google Patents

Pharmaceutical composition comprising a salt of mirtazapine

Info

Publication number: ZA200608305B
Authority: ZA; South Africa
Prior art keywords: mirtazapine; salt; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2004-04-21

Application number

ZA200608305A

Other languages

English (en)

Inventor

Sytske Hyke Moolenaar

Der Voort Maarschalk Kees Van

Gerardus Johannes Kemperman

Original Assignee

Organon Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-21

Filing date

2006-10-05

Publication date

2008-08-27

2006-10-05 Application filed by Organon Nv filed Critical Organon Nv

2008-08-27 Publication of ZA200608305B publication Critical patent/ZA200608305B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

ZA200608305A 2004-04-21 2006-10-05 Pharmaceutical composition comprising a salt of mirtazapine ZA200608305B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04101664		2004-04-21

Publications (1)

Publication Number	Publication Date
ZA200608305B true ZA200608305B (en)	2008-08-27

Family

ID=34928990

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200608305A ZA200608305B (en)	2004-04-21	2006-10-05	Pharmaceutical composition comprising a salt of mirtazapine

Country Status (31)

Country	Link
US (1)	US20070111993A1 (es)
EP (1)	EP1729777B1 (es)
JP (2)	JP5260959B2 (es)
CN (2)	CN101824035A (es)
AR (1)	AR049028A1 (es)
AT (1)	ATE424210T1 (es)
AU (1)	AU2005235383B2 (es)
BR (1)	BRPI0509953A (es)
CA (1)	CA2561281C (es)
CY (1)	CY1109018T1 (es)
DE (1)	DE602005013066D1 (es)
DK (1)	DK1729777T3 (es)
EC (1)	ECSP066938A (es)
ES (1)	ES2321961T3 (es)
HR (1)	HRP20090190T1 (es)
IL (1)	IL178201A (es)
LV (1)	LV13556B (es)
MX (1)	MXPA06011830A (es)
MY (1)	MY144899A (es)
NO (1)	NO20065077L (es)
NZ (1)	NZ550052A (es)
PE (1)	PE20060400A1 (es)
PL (1)	PL1729777T3 (es)
PT (1)	PT1729777E (es)
RS (1)	RS50764B (es)
RU (1)	RU2375362C2 (es)
SI (1)	SI1729777T1 (es)
TW (1)	TW200538100A (es)
UA (1)	UA89773C2 (es)
WO (1)	WO2005102352A1 (es)
ZA (1)	ZA200608305B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA83666C2 (ru) *	2003-07-10	2008-08-11	Н.В. Органон	Способ получения энантиомерно чистого миртазапина
EP1792618A1 (en) *	2005-11-30	2007-06-06	Rainer Freynhagen	R-mirtazapine for the treatment of pain
TW200808804A (en) *	2006-05-22	2008-02-16	Organon Nv	Mirtazapine for the treatment of neuropathic pain
CN104095824B (zh) *	2013-04-09	2016-08-31	上海信谊万象药业股份有限公司	一种米氮平缓释片及其制备方法
US10603272B2 (en)	2015-02-27	2020-03-31	Kindred Biosciences, Inc.	Stimulation of appetite and treatment of anorexia in dogs and cats
CN111053735A (zh) *	2020-02-25	2020-04-24	上海阶平医院管理有限公司	一种治疗失眠的冷敷凝胶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL189199C (nl) *	1975-04-05	1993-02-01	Akzo Nv	Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4193828A (en) *	1976-07-27	1980-03-18	Fiber Materials, Inc.	Method of forming carbon composites
US4515792A (en) *	1982-09-30	1985-05-07	Ciba-Geigy Corporation	Tetracyclic heterocycles and antidepressant compositions thereof
EP0813873B1 (en) *	1996-06-19	2002-02-13	Akzo Nobel N.V.	Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) *	1996-06-19	2000-10-31	Akzo Nobel Nv	Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
AU747975B2 (en) *	1998-04-02	2002-05-30	N.V. Organon	Oral liquid antidepressant solution
WO2001000196A2 (en) *	1999-06-25	2001-01-04	University Of South Florida	Mirtazapine for weight gain in wasting diseases
US6281207B1 (en) *	1999-09-15	2001-08-28	Reed Richter	Treatment of movement disorders by administration of mirtazapine
AU6474200A (en) *	1999-12-13	2001-06-18	Sumika Fine Chemicals Co., Ltd.	Process for the preparation of a pyridinemethanol compound
HK1047547B (en) *	2000-04-05	2003-10-10	Akzo Nobel N.V.	Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug

2005
- 2005-04-12 TW TW094111559A patent/TW200538100A/zh unknown
- 2005-04-19 CN CN201010174000A patent/CN101824035A/zh active Pending
- 2005-04-19 BR BRPI0509953-6A patent/BRPI0509953A/pt not_active IP Right Cessation
- 2005-04-19 NZ NZ550052A patent/NZ550052A/en unknown
- 2005-04-19 RS RSP-2009/0164A patent/RS50764B/sr unknown
- 2005-04-19 AT AT05740221T patent/ATE424210T1/de active
- 2005-04-19 DE DE602005013066T patent/DE602005013066D1/de not_active Expired - Lifetime
- 2005-04-19 UA UAA200610312A patent/UA89773C2/ru unknown
- 2005-04-19 MY MYPI20051731A patent/MY144899A/en unknown
- 2005-04-19 PT PT05740221T patent/PT1729777E/pt unknown
- 2005-04-19 US US11/547,152 patent/US20070111993A1/en not_active Abandoned
- 2005-04-19 DK DK05740221T patent/DK1729777T3/da active
- 2005-04-19 CA CA2561281A patent/CA2561281C/en not_active Expired - Fee Related
- 2005-04-19 RU RU2006140988/04A patent/RU2375362C2/ru not_active IP Right Cessation
- 2005-04-19 CN CN2005800116628A patent/CN1942191B/zh not_active Expired - Fee Related
- 2005-04-19 PL PL05740221T patent/PL1729777T3/pl unknown
- 2005-04-19 MX MXPA06011830A patent/MXPA06011830A/es not_active IP Right Cessation
- 2005-04-19 JP JP2007508904A patent/JP5260959B2/ja not_active Expired - Fee Related
- 2005-04-19 ES ES05740221T patent/ES2321961T3/es not_active Expired - Lifetime
- 2005-04-19 WO PCT/EP2005/051714 patent/WO2005102352A1/en not_active Ceased
- 2005-04-19 HR HR20090190T patent/HRP20090190T1/xx unknown
- 2005-04-19 AU AU2005235383A patent/AU2005235383B2/en not_active Expired
- 2005-04-19 SI SI200530673T patent/SI1729777T1/sl unknown
- 2005-04-19 EP EP05740221A patent/EP1729777B1/en not_active Expired - Lifetime
- 2005-04-20 PE PE2005000439A patent/PE20060400A1/es not_active Application Discontinuation
- 2005-04-20 AR ARP050101549A patent/AR049028A1/es unknown
2006
- 2006-09-20 IL IL178201A patent/IL178201A/en not_active IP Right Cessation
- 2006-10-05 ZA ZA200608305A patent/ZA200608305B/xx unknown
- 2006-10-19 EC EC2006006938A patent/ECSP066938A/es unknown
- 2006-11-03 NO NO20065077A patent/NO20065077L/no not_active Application Discontinuation
- 2006-11-21 LV LVP-06-130A patent/LV13556B/lv unknown
2009
- 2009-05-05 CY CY20091100481T patent/CY1109018T1/el unknown
2013
- 2013-03-08 JP JP2013046645A patent/JP2013136626A/ja active Pending

Also Published As

Publication number	Publication date
SI1729777T1 (sl)	2009-08-31
RU2006140988A (ru)	2008-05-27
NO20065077L (no)	2006-11-14
NZ550052A (en)	2010-02-26
ATE424210T1 (de)	2009-03-15
LV13556B (en)	2007-07-20
MY144899A (en)	2011-11-30
CN101824035A (zh)	2010-09-08
JP2013136626A (ja)	2013-07-11
IL178201A0 (en)	2006-12-31
PT1729777E (pt)	2009-04-27
PL1729777T3 (pl)	2009-07-31
ECSP066938A (es)	2006-12-20
CN1942191A (zh)	2007-04-04
HRP20090190T1 (en)	2009-05-31
JP2007533705A (ja)	2007-11-22
US20070111993A1 (en)	2007-05-17
CA2561281A1 (en)	2005-11-03
BRPI0509953A (pt)	2007-09-25
PE20060400A1 (es)	2006-05-27
UA89773C2 (ru)	2010-03-10
AU2005235383A1 (en)	2005-11-03
WO2005102352A1 (en)	2005-11-03
CN1942191B (zh)	2011-02-02
JP5260959B2 (ja)	2013-08-14
DK1729777T3 (da)	2009-06-08
IL178201A (en)	2010-06-30
DE602005013066D1 (de)	2009-04-16
EP1729777B1 (en)	2009-03-04
TW200538100A (en)	2005-12-01
EP1729777A1 (en)	2006-12-13
MXPA06011830A (es)	2007-03-23
AR049028A1 (es)	2006-06-21
ES2321961T3 (es)	2009-06-15
RU2375362C2 (ru)	2009-12-10
CY1109018T1 (el)	2014-07-02
CA2561281C (en)	2013-04-02
RS50764B (sr)	2010-08-31
AU2005235383B2 (en)	2010-05-27

Publication	Publication Date	Title
ZA200606229B (en)	2009-12-30	A pharmaceutical composition
ZA200703312B (en)	2008-09-25	Pharmaceutical compounds
EP1765283A4 (en)	2012-11-28	PHARMACEUTICAL COMPOSITIONS
IL177480A0 (en)	2006-12-10	Pharmaceutical composition
IL182703A0 (en)	2007-09-20	Pharmaceutical compositions comprising a camtothecin derivative
IL181229A0 (en)	2007-07-04	Noncardiotoxic pharmaceutical compounds
EP1776112A4 (en)	2009-11-25	HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS
HU0401177D0 (en)	2004-08-30	Pharmaceutical composition
GB2411355B (en)	2006-02-22	Pharmaceutical composition
EP1805154A4 (en)	2009-11-25	PHARMACEUTICAL COMPOSITIONS
GB0400452D0 (en)	2004-02-11	A pharmaceutical composition
ZA200608305B (en)	2008-08-27	Pharmaceutical composition comprising a salt of mirtazapine
GB0425255D0 (en)	2004-12-15	Pharmaceutical composition
ZA200701932B (en)	2008-08-27	Pharmaceutical composition
GB0424742D0 (en)	2004-12-08	Pharmaceutical compounds
ZA200701931B (en)	2008-10-29	Pharmaceutical composition
GB0428554D0 (en)	2005-02-09	Pharmaceutical compounds
GB0407351D0 (en)	2004-05-05	Pharmaceutical compositions
HK1095098A (en)	2007-04-27	Pharmaceutical composition comprising a salt of mirtazapine
GB0400971D0 (en)	2004-02-18	Pharmaceutical compositions
PL373776A1 (en)	2005-10-03	Oral pharmaceutical compound
GB0402799D0 (en)	2004-03-10	Pharmaceutical composition
GB0415084D0 (en)	2004-08-04	Pharmaceutical compounds
GB0412894D0 (en)	2004-07-14	Pharmaceutical compounds
GB0416373D0 (en)	2004-08-25	Pharmaceutical compounds